Gene Query: RAB3IP

Dataset Description Geneva Score
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 58.62
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 56.19
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 56.19
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 30.49
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 28.78
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 27.57
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 27.57
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 23.66
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 22.78
Developmental stage specific chromosome architecture in human erythroid cells 22.78
Regionally specified human pluripotent stem cell-derived astrocytes 20.11
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 18.61
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 17.15
Expression by CD133+ cells isolated from the adult human exocrine pancreas 16.13
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 15.72
RNA sequencing of BT142 and TS603 cell lines 15.04
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 15.04
Genome-wide identification of cancer-specific alternative splicing in circRNA 14.98
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 14.31
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 14.24
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 13.94
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 13.9
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 13.9
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 13.85
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 13.78
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 13.37
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 13.24
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 13.06
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 12.96
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 12.84
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 12.84
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 12.67
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 12.54
Transcriptome analysis of U87 cells upon LINC00152 knockdown 12.38
MEIS1 regulates hematopoiesis in hPSCs 12.31
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 12.25
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 11.93
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 11.93
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 11.68
Role of FGFR1 in neuronal devlopment 11.55
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 11.26
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 11.1
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 11.04
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 10.96
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 10.89
Human cell line and subcutaneous tumor 10.75
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 10.33
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 10.02
Gene expression alterations of pancreatic intraepithlial neoplasia 9.93
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 9.8
Differentially expressed genes post knock down of lincDUSP26 9.73
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 9.48
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 9.39
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 9.38
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 9.32
A prostate cancer chromatin interaction map 9.11
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 8.98
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 8.96
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 8.94
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 8.94
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 8.85
Ectoderm specification of H1 human embryonic stem cells 8.81
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 8.73
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 8.71
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 8.5
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 8.5
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 8.47
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 8.44
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 8.34
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 8.3
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 8.3
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 8.28
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 8.26
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 8.15
Selective suppression of endothelial cytokine production by progesterone receptor 8.15
Global transcriptome analysis of HAP1 cells 8.1
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 8.02
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 7.91
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 7.87
Hijacking of stress response machinery by oncogenes in acute leukaemia 7.87
RNA-seq analyses of human prostate cancer cells 7.85
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 7.81
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 7.81
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 7.76
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 7.76
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 7.75
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 7.73
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 7.71
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 7.69
MYCi361 regulates MYC target genes 7.66
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 7.62
IDH3a KO RNA-seq 7.62
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 7.55
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 7.5
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 7.38
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 7.37
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 7.36
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 7.34
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 7.32
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 7.32
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 7.31
HNRNPM-regulated splicing dependencies in prostate cancer 7.31
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 7.29
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 7.28
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 7.27
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 7.21
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 7.21
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 7.21
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 7.13
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 7.09
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 7.07
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 7.06
Gene expression changes upon drug withdrawal (Mel888 cell line) 7.04
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 6.96
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 6.95
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 6.93
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 6.9
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 6.9
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 6.9
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 6.82
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 6.77
The comparison of high-throughput single-cell RNA-seq methods 6.76
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 6.71
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 6.69
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 6.65
Short and Long RNA sequencing of human mature erythrocytes 6.64
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 6.61
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 6.51
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 6.48
Neonatal and adult human testis defined at the single-cell level 6.47
Comparing gene expression in iPSC derived RPE from control and AMD donors 6.46
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 6.46
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 6.44
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 6.44
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 6.44
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 6.34
ARID1A and ARID1B loss in HCT116 cells 6.29
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 6.28
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 6.27
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 6.24
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 6.24
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 6.24
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 6.23
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 6.23
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 6.21
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 6.21
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 6.2
LINE-2 transposable elements are a source of functional human microRNAs and target sites 6.16
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 6.16
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 6.13
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 6.13
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 6.08
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 5.99
Transcriptomic analysis of frontal fibrosing alopecia 5.93
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 5.93
Primary human trophoblast from term placenta 5.93
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 5.9
Region-specific Innate Antiviral Responses of the Human Epididymis 5.84
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 5.83
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 5.82
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 5.81
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 5.79
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 5.77
Toxoplasma gondii infection of human retinal pigment epithelial cells 5.73
The Human Testis Cell Atlas via Single-cell RNA-seq 5.72
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 5.72
LncRNA-GAS5 negative regulation of YAP-target genes expression 5.69
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 5.64
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 5.64
The transcriptome and chromatin accessbility landscape of mammalian germline 5.62
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 5.62
The conserved transcriptional landscapes in human spermatogenesis 5.59
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 5.57
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 5.57
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 5.56
mRNA-Seq profiling of human developing kidney 5.49
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 5.48
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 5.43
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 5.42
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 5.4
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 5.35
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 5.35
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 5.34
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 5.34
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 5.33
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 5.33
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 5.29
HNF1 regulates critical functions of the human epididymis epithelium. 5.29
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 5.28
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 5.26
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 5.23
Novel Targeting of Transcription and Metabolism in Glioblastoma 5.23
LIN28A Over-expression RNAseq 5.17
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 5.14
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 5.09
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 5.08
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 5.01
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 5.01
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 5.0
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 5.0
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 4.99
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 4.93
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 4.86
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 4.84
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 4.84
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 4.83
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 4.82
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 4.79
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 4.78
Direct Isolation and Characterization of Human Nephron Progenitors. 4.76
U2AF1 mutations alter splice site recognition in hematological malignancies 4.76
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 4.76
Oncogenic MYC induces a dependency on the spliceosome in human cancer 4.75
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 4.74
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 4.73
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 4.73
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 4.73
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 4.64
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 4.64
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 4.64
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 4.63
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 4.61
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 4.58
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 4.58
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 4.55
Co-regulation of splicing by Rbfox1 and hnRNP M 4.55
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 4.55
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 4.53
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 4.53
IRF1 regulates IFN dependent and independent gene expression 4.5
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 4.5
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 4.49
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 4.48
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 4.47
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 4.45
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 4.45
Effect of disulfiram treatment on pediatric high grade glioma 4.44
Gene expressions of H9s in different culture systems 4.43
FOXP1 orchestration of ASD-relevant signaling pathways. 4.41
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 4.34
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 4.33
Characterization of the Merkel cell carcinoma miRNome 4.32
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 4.3
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 4.29
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 4.28
Global response to chemotherapy-induced apoptosis 4.27
Transcriptome analysis of SKI knock-out in HL60 cells 4.24
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 4.24
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 4.21
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 4.2
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 4.18
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 4.18
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 4.17
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 4.17
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 4.11
Global Mapping of Human RNA-RNA Interactions 4.1
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 4.1
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 4.08
RNAseq of IL-36 stimulated primary human keratinocytes 4.07
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 4.04
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 4.0
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 4.0
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 3.95
NKX2.2 3.95
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 3.89
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 3.89
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 3.83
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 3.81
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 3.81
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  3.79
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 3.78
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 3.77
Transcriptomes in healthy and CHB fetal hearts 3.74
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 3.73
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 3.7
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 3.68
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 3.67
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 3.67
Cleavage Factor Im as a key regulator of 3’ UTR length 3.65
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 3.64
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 3.64
Generation of KRAS signatures using immortalized isogenic lung cells. 3.64
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 3.63
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 3.61
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 3.61
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 3.58
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 3.58
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 3.57
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 3.56
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 3.56
The gene expression profiles of gallbladder cancer 3.51
MCF-7 as a model for functional analysis of breast cancer risk variants 3.5
RNA-seq of RKO cells with cTAZ KO or putback 3.49
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 3.46
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 3.45
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 3.44
Transcriptional dependencies in diffuse intrinsic pontine glioma 3.43
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 3.42
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 3.4
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 3.4
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 3.38
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 3.37
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 3.37
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 3.32
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 3.3
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 3.28
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 3.28
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 3.23
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 3.2
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 3.16
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 3.15
Androgen Receptor-regulated genes in prostate cancer cells 3.14
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 3.14
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 3.12
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 3.12
Global transcriptome analysis of WT versus HEB-/- hESCs 3.11
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 3.07
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 3.05
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 3.04
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 3.01
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 3.0
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 3.0
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 2.99
Effect of nuclear IL-33 on gene expression 2.98
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 2.97
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 2.94
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 2.93
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 2.93
Gene expression profile in breast cancer cell lines using RNA sequencing 2.91
Gene expression profiling in metabolically heterogeneous human lung tumors 2.85
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 2.83
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 2.76
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 2.74
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 2.74
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 2.7
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 2.69
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 2.69
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 2.67
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 2.66
scRNASeq analysis of cycling cardiomyocytes 2.63
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 2.61
PTHrP overexpression in MCF7 cells 2.6
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 2.6
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 2.59
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 2.57
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 2.56
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 2.54
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 2.52
Common inflammatory pathways between NEC and Crohn's disease 2.51
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 2.45
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 2.42
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 2.39
Widespread intronic polyadenylation diversifies immune cell transcriptomes 2.31
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 2.3
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 2.28
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 2.28
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 2.24
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 2.22
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 2.22
RNA Sequencing of Human iPS derived Cardiomyocytes 2.21
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 2.17
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 2.17
Identification of a LIF-responsive replication-competent human β cell 2.14
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 2.11
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 2.11
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 2.09
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 2.08
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 2.08
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 2.08
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 2.04
Gene expression analysis of human hepatocellular cancers 2.01
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 1.97
RNA-seq analysis of the human fetal kidney. 1.95
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 1.93
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 1.92
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 1.9
Effect of BMP inhibition or stimulation of primary human keratinocytes 1.9
The contribution of Alu exons to the human proteome 1.89
High-resolution comparative analysis of great ape genomes 1.83
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 1.78
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 1.77
The Glioma-Infiltrating T Cell Receptor Repertoire 1.76
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 1.76
Oncogenic roles of ARID5B in T-ALL 1.76
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 1.74
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 1.73
Gene expression changes due to PARP knockdown in human cells 1.72
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 1.72
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.7
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.69
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.69
Next generation sequencing of small RNAs isolated from exosomes in human semen 1.66
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 1.65
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.63
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 1.59
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 1.58
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 1.58
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 1.57
Transposon-based construction of strand-specific RNA-seq libraries 1.54
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 1.52
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 1.52
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 1.52
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 1.52
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 1.52
RNA-seq of SCLC PDX models treated with EP 1.49
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 1.46
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 1.46
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 1.42
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 1.42
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 1.41
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 1.41
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 1.4
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 1.38
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 1.37
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 1.36
iPSC-Derived Cholangiocytes 1.34
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 1.33
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 1.32
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 1.31
Transcriptome analysis of kidney organoids 1.3
RNAseq of T-ALL upon long non coding rna purturbation 1.3
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 1.27
Age-Related Gene Expression Changes in Prostate Cancer Patients 1.27
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 1.2
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 1.18
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 1.17
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 1.12
Molecular analysis of renal cell carcinoma with unclassfied histology 1.12
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 1.11
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.06
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 1.06
Expression charcaterization of an internal protocol developed to differentiate RPE cells 1.06
circNFIB suppresses lymphatic metastasis of pancreatic cancer 1.04
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 1.03
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 1.01
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 1.01
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 1.01
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 1.0
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 1.0
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.99
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.99
A novel target of EZH1/2 for treatment of mantle cell lymphoma 0.96
Transcriptional landscape changes during human embryonic stem cell derivation 0.9
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.87
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 0.86
Functional significance of the HIV-1 Tat signature amino acid residues 0.85
Total RNA-Seq data from leukemic patients with complex structural variants 0.85
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 0.81
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 0.78
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.73
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.73
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 0.68
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 0.66
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.61
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.6
Identification of expressed and conserved human non-coding RNAs 0.56
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.54
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.52
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.51
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.51
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 0.51
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 0.5
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.49
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 0.46
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 0.46
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.46
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 0.46
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 0.45
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.44
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.44
The age and genomic integrity of neurons after cortical stroke in humans 0.41
Impact on erythroid progenitor type on erythroid differntiation 0.41
Gene expression of collecting duct carcinoma of the kidney 0.39
Transcriptome analyses of human pancreatic islets and pseudoislets 0.39
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.39
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.39
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.38
RNAseq analysis of ruxolitinib treated breast cancers 0.34
hNSCs siRNA NOVA2 0.32
Epigenomic conservation of transposable element silencing [RNA-seq] 0.27
Epigenomic conservation of transposable element silencing 0.27
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.26
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.23
Epigenome regulation during epidermal lineage commitment [RNA-seq] 0.22
RNA-Seq in PWS iPSC-derived neurons 0.2
Modulation of nonsense-mediated decay by rapamycin 0.2
Ribosomal protein RPL26 is the principal target of UFMylation 0.2
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.2
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.18
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.18
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.18
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.18
In vitro modeling of human germ cell development using pluripotent stem cells 0.17
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.17
SOX11 knockdown in B-ALL cell lines 0.08
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.08
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.04
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 0.02
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.02
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation